STIM

STIM

USD

Neuronetics Inc. Common Stock

$2.870+0.490 (20.588%)

Preço em tempo real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$2.380

Máximo

$3.090

Mínimo

$2.380

Volume

0.12M

Fundamentos da empresa

Capitalização de mercado

189.8M

Setor

Dispositivos médicos

País

United States

Estatísticas de negociação

Volume médio

1.33M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.52Atual $2.870Máximo $5.92

Notícias relacionadas

GlobeNewswire

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% on an adjusted

Ver mais
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
GlobeNewswire

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life

Ver mais
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

Ver mais
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
GlobeNewswire

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

Ver mais
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.